Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ImmunGene logo — Innovation in antibody-cytokine fusion technology and monocl...

ImmunGene

Innovation in antibody-cytokine fusion technology and monoclonal antibody-based therapies for a brighter future in cancer and autoimmune disease treatment.

Founded 2007 Series A Total: $9.00M Biotechnology, Health and Wellness +1

General Information

Company Name ImmunGene
Founded Year 2007
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with ImmunGene. To contact ImmunGene, visit immungene.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About ImmunGene

**ImmunGene** is an innovative biotechnology company founded in 2007, focused on advancing antibody-cytokine fusion technology and monoclonal antibody-based therapies for the treatment of cancer, autoimmune disorders, and other diseases. The company's multiple programs at various development stages have garnered significant attention and support. ImmunGene has received funding from federal government grants, such as the **NIH-SBIR**, and from private investors, including notable biotechnology industry executives. The most recent investment was a **$9.00M Series A** investment on **07 November 2013**, led by **Ally Bridge Group**. ImmunGene operates in the biotechnology, health and wellness, and pharmaceutical industries, positioning itself as a promising player in the advancement of treatment options for oncological and autoimmune conditions.

Taxonomy: Antibody-cytokine fusion, Monoclonal antibodies, Cancer treatment, Autoimmune disorders, Therapeutic innovation, Drug development, Research and development, Funding, NIH-SBIR, Private investment, Biotechnology executives, Innovative therapies, Immunotherapy, Medical advancements

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $9.00M 1
Ally Bridge Group
Ally Bridge Group
07 Nov 2013

ImmunGene Alternatives & Competitors

ImmunGene vs
NEOVACS
NEOVACS France

Nous développons les thérapies de demain et investissons dans des sociétés innovantes en Biotech et...

Post-IPO Equity
18 employees
Biotechnology, Health Care
ImmunGene vs
Antharis Therapeutics, Inc.
Antharis Therapeutics, Inc. United States

Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting-edge trea...

18 employees
Biopharma, Biotechnology
ImmunGene vs
Kanova
Kanova

Pioneering advanced therapies in immuno-oncology and autoimmune diseases.

Series B
2-10 employees
Biopharma, Health and Wellness

FAQ About ImmunGene

Innovation in antibody-cytokine fusion technology and monoclonal antibody-based therapies for a brighter future in cancer and autoimmune disease treatment.
ImmunGene was founded in 2007.
ImmunGene operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on Antibody-cytokine fusion, Monoclonal antibodies, Cancer treatment and Autoimmune disorders.
ImmunGene has completed 1 funding round, raising a total of $9.00M. The latest funding stage is Series A.
Top alternatives and competitors to ImmunGene include NEOVACS, Antharis Therapeutics, Inc., Kanova, Bright Peak Therapeutics, Acticor Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ImmunGene and NEOVACS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ImmunGene, https://bouncewatch.com/company/immungene, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes